down arrow

Windlas Biotech

45
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
960.45
63.55 (7.09%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 51.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
630.00
513.00
465.00
427.00
328.00
307.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
630.00
513.00
465.00
427.00
328.00
307.00
Expenditure (Ex Depriciation)
Stock Adjustments
9.00
-15.00
-4.00
3.00
-12.00
3.00
Raw Materials Consumed
386.00
340.00
307.00
270.00
224.00
188.00
Power & Fuel Cost
16.00
12.00
11.00
11.00
8.00
7.00
Employee Cost
87.00
70.00
63.00
58.00
43.00
42.00
Operating Expenses
10.00
8.00
8.00
8.00
4.00
5.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
15.00
10.00
6.00
4.00
6.00
3.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
6.00
5.00
3.00
5.00
3.00
3.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
552.00
452.00
413.00
372.00
287.00
268.00
Operating Profit (PBDIT) excl Other Income
78.00
60.00
52.00
54.00
41.00
38.00
Other Income
13.00
9.00
6.00
3.00
2.00
4.00
Operating Profit (PBDIT)
91.00
70.00
59.00
57.00
43.00
42.00
Interest
1.00
0.00
1.00
1.00
2.00
4.00
Profit before Depriciation and Tax
90.00
69.00
57.00
56.00
41.00
37.00
Depreciation
13.00
12.00
12.00
12.00
9.00
10.00
Profit Before Taxation & Exceptional Items
77.00
57.00
45.00
43.00
32.00
27.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
77.00
57.00
45.00
21.00
24.00
76.00
Provision for Tax
18.00
14.00
7.00
6.00
8.00
12.00
Profit After Tax
58.00
42.00
38.00
15.00
23.00
64.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
176.00
141.00
103.00
114.00
98.00
34.00
Profit Available for appropriations
234.00
184.00
141.00
129.00
114.00
97.00
Appropriations
234.00
184.00
141.00
129.00
114.00
97.00
Equity Dividend (%)
110.00%
80.00%
70.00%
0.00%
0.00%
0.00%
Earnings Per Share
27.97
19.70
18.58
8.70
8.90
38.61
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 22.97% vs 10.12% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 29.80% vs 14.88% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 40.23% vs -44.39% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 36.51% vs 11.91% in Mar 2023

Compare Profit and Loss Results of Windlas Biotech
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
630.00
10,334.00
-9,704.00
-93.90%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
630.00
10,334.00
-9,704.00
-93.90%
Expenditure (Ex Depriciation)
Stock Adjustments
9.00
-94.00
103.00
109.57%
Raw Materials Consumed
386.00
3,263.00
-2,877.00
-88.17%
Power & Fuel Cost
16.00
129.00
-113.00
-87.60%
Employee Cost
87.00
2,274.00
-2,187.00
-96.17%
Operating Expenses
10.00
210.00
-200.00
-95.24%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
15.00
928.00
-913.00
-98.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
134.00
-128.00
-95.52%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
552.00
7,798.00
-7,246.00
-92.92%
Operating Profit (PBDIT) excl Other Income
78.00
2,536.00
-2,458.00
-96.92%
Other Income
13.00
280.00
-267.00
-95.36%
Operating Profit (PBDIT)
91.00
2,817.00
-2,726.00
-96.77%
Interest
1.00
35.00
-34.00
-97.14%
Profit before Depriciation and Tax
90.00
2,782.00
-2,692.00
-96.76%
Depreciation
13.00
398.00
-385.00
-96.73%
Profit Before Taxation & Exceptional Items
77.00
2,384.00
-2,307.00
-96.77%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
77.00
2,399.00
-2,322.00
-96.79%
Provision for Tax
18.00
457.00
-439.00
-96.06%
Profit After Tax
58.00
1,926.00
-1,868.00
-96.99%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
176.00
8,012.00
-7,836.00
-97.80%
Profit Available for appropriations
234.00
9,925.00
-9,691.00
-97.64%
Appropriations
234.00
9,925.00
-9,691.00
-97.64%
Equity Dividend (%)
110%
0%
110.00
Earnings Per Share
27.97
47.75
-19.78
-41.42%
Profit And Loss - Net Sales
Net Sales 630.96 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 22.97% vs 10.12% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 78.17 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 29.80% vs 14.88% in Mar 2023

Profit And Loss - Interest
Interest 1.10 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 40.23% vs -44.39% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 58.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.51% vs 11.91% in Mar 2023